Blu – Pagina 119 – AMD

Blu

Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.

Ottobre 20, 2023 dario.olivero

Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target trial

Russell-Jones D, Babazono T, Cailleteau R, et al.
The Lancet. Pub. online 17 Oct 2023.

Leggi

Ottobre 20, 2023 dario.olivero

Proportion of participants with type 2 diabetes achieving a metabolic composite endpoint with once‐weekly semaglutide treatment versus comparators: Post hoc pooled analysis from SUSTAIN 1‐5, 7‐10 and SUSTAIN China

Ji L, Ahmann AJ, Ahrén B, et al.
Diabetes Obes Metab. Pub. online 12 Oct 2023.

Leggi

Ottobre 20, 2023 dario.olivero

Construction and validation of a nomogram for predicting diabetes remission at 3 months after bariatric surgery in patients with obesity combined with type 2 diabetes mellitus

Yuan K, Wu B, Zeng R, et al.
Diabetes Obes Metab. Pub. online 9 Oct 2023.

Leggi

Ottobre 20, 2023 dario.olivero

CamAPS FX hybrid closed-loop with ultra-rapid lispro compared with standard lispro in adults with type 1 diabetes: a double-blind, randomized, crossover study

Nwokolo M, Lakshman R, Hartnell S, et al.
Diabetes Technol Ther. Pub. online 12 Oct 2023.

Leggi

Ottobre 16, 2023 dario.olivero

Dapagliflozin and physical and social activity limitations in heart failure with reduced ejection fraction

Butt JH, Docherty KF, Kosiborod MN, et al.
J Am Coll Cardiol HF. 2023, 11 (10) 1411–1423.

Leggi

Ottobre 16, 2023 dario.olivero

Listening to women: experiences of using closed-loop in type 1 diabetes pregnancy

Lawton J, Kimbell B, Closs M, et al.
Diabetes Technol Ther. Pub. online 5 Oct 2023.

Leggi

Ottobre 16, 2023 dario.olivero

A european cost-utility analysis of the MiniMed^TM 780g advanced hybrid closed-loop system versus intermittently scanned continuous glucose monitoring with multiple daily insulin injections in people living with type 1 diabetes

Jendle J, Buompensiere MI, Saltik AZO, et al.
Diabetes Technol Ther. Pub. online 6 Oct 2023.

Leggi

Ottobre 16, 2023 dario.olivero

Faster-acting insulin aspart versus insulin aspart in the treatment of type 1 or type 2 diabetes during pregnancy and post-delivery (CopenFast): an open-label, single-centre, randomised controlled trial

Nørgaard SK, Søholm JC, Mathiesen ER, et al.
Lancet Diabetes Endocrinol. 2023:S2213-8587(23)00236-X.

Leggi

Ottobre 16, 2023 dario.olivero

Precision medicine of obesity as an integral part of type 2 diabetes management – past, present, and future

Szczerbinski L, Florez JC
Lancet Diabetes Endocrinol. 2023:S2213-8587(23)00232-2.

Leggi

Ottobre 16, 2023 dario.olivero

Semaglutide effects according to ejection fraction in heart failure with preserved ejection fraction and obesity

Butler J, Abildstrøm SZ, Borlaug BA, et al.
J Am Coll Cardiol. Pub. online 08 Oct 2023.

Leggi